Hiroshi Honda

ORCID: 0000-0003-0943-6583 · 4 papers in corpus
article 2023
Genome-Wide Gene Expression Profiling Reveals the Direct Effect of Dienogest on Ovarian Endometriotic Stromal Cells
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-023-01181-4

Endometriosis affects up to 10% of women of reproductive age, causing dysmenorrhea, chronic pelvic pain, and infertility. The current key drug for endometriosis is dienogest, a progestin with high specificity for the progesterone receptor. …

preprint 2020
Dienogest exerts its anti-endometriotic effect throughthe direct suppression of matrix metallopeptidases
·doi:10.21203/rs.3.rs-84809/v1

Abstract Background: Endometriosis, which affects up to 10% women of reproductive age, is defined by the presence of ectopic endometrial tissue outside the uterus. The current key drug of hormonal therapies for endometriosis is dienogest, …

article 2016
Mass-forming Retroperitoneal Endometriosis Including a Fat Component: A Diagnostic Dilemma
Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine ·doi:10.2463/mrms.ci.2016-0078
article 2008
Serial analysis of gene expression reveals differential expression between endometriosis and normal endometrium. Possible roles for AXL and SHC1 in the pathogenesis of endometriosis
Reproductive biology and endocrinology : RB&E ·doi:10.1186/1477-7827-6-59

BACKGROUND: Endometriosis is a clinical condition that affects up to 10% of the women of reproductive age. Endometriosis is characterized by the presence of endometrial tissues outside the uterine cavity and can lead to chronic pelvic pain,…